4//SEC Filing
HILL CHARLES H 4
Accession 0001225208-18-005098
CIK 0000078003other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 3:24 PM ET
Size
16.3 KB
Accession
0001225208-18-005098
Insider Transaction Report
Form 4
PFIZER INCPFE
HILL CHARLES H
Executive Vice President
Transactions
- Sale
Common Stock
2018-02-28$36.84/sh−1,100$40,524→ 206,842 total - Sale
Common Stock
2018-02-28$36.82/sh−5,400$198,828→ 198,242 total - Tax Payment
Common Stock
2018-02-28$36.31/sh−19,606$711,894→ 161,557 total - Sale
Common Stock
2018-02-28$36.83/sh−17,079$629,020→ 181,163 total - Tax Payment
Common Stock
2018-02-28$35.70/sh−61,836$2,207,545→ 99,721 total - Exercise/Conversion
Stock Appreciation Rights
2018-02-28−101,872→ 0 totalExercise: $27.37From: 2018-02-28Exp: 2018-02-28→ Common Stock (101,872 underlying) - Exercise/Conversion
Common Stock
2018-02-28$27.37/sh+101,872$2,788,237→ 207,942 total - Sale
Common Stock
2018-02-28$36.85/sh−3,200$117,920→ 203,642 total
Holdings
- 11,414(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001508517
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 3:24 PM ET
- Size
- 16.3 KB